Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2016-03-22 Director's Dealing
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-03-22 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC by Amphastar Pharmaceuticals, Inc. on March 15, 2016. Form S-8 is used to register securities to be offered under employee benefit plans, such as equity incentive plans. The document includes details about the registration of additional shares under the 2015 Equity Incentive Plan, references to prior filings, and legal indemnification provisions. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not a brief announcement or a report publication announcement but a substantive regulatory filing.
2016-03-15 English
10-K
Annual Report FY 2015
2016-03-15 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company issued a press release announcing its financial results for the quarter ended December 31, 2015, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references the press release. The length of the document is 3273 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces or furnishes a press release of quarterly financial results should be classified as an Earnings Release (ER).
2016-03-14 English
SC 13G AMENDMENT NO. 1
Major Shareholding Notification
2016-02-16 English
FORM 4 SUBMISSION
Director's Dealing
2016-02-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.